R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
News Change at the top of Recursion as co-founder leaves CEO role After 12 years as CEO of 'techbio' player Recursion, Chris Gibson is switching to the role of chair and will be replaced by Najat Khan.
R&D Changing Faces – Boards of Directors and Advisory Boards – A... Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to report on.
Sales & Marketing Changing Faces – Agency, investor, and legal hires – August ... In the agency and investor worlds, August and September hires were light volume-wise, but did include big changes at the top of the totem pole.
Digital Changing Faces – Digital and supplier hires – August and Sep... There was plenty of personnel action in August and September among pharmaceutical suppliers, particularly in the clinical trial technology sector.
News Organon CEO resigns over 'improper' contraceptive sales Organon CEO Kevin Ali has stepped down after an audit found sales of the company's Nexplanon contraceptive implant in the US were inflated.
Patients Biosimilars & patient access independent of geographies or s... Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
